Clinical Trials Directory

Trials / Completed

CompletedNCT02249234

Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

There are no previous reports on the use of OnabotulinumtoxinA (Botox) to treat men with scrotal pain that we found published. We proposed a pilot study using Botox to block the nerves on a small group of men with chronic scrotal pain (CSP) who have failed the standard medical therapy. The men must have had temporary relief from a testicular cord block using local anaesthetic drug. The encourage results of the pilot study has given us the background information to proceed with a formal randomised control trial of Botox vs placebo. We hypothesized that Botox injections to block the testicular nerve will be effective in providing long term pain relief for men with scrotal pain.

Conditions

Interventions

TypeNameDescription
DRUGBotox
DRUGPlacebo

Timeline

Start date
2014-08-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2014-09-25
Last updated
2019-03-11

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02249234. Inclusion in this directory is not an endorsement.

Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain (NCT02249234) · Clinical Trials Directory